MGMT-Unmethylated Glioblastoma — Trials

MGMT-Unmethylated Glioblastoma — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 7
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Northwestern University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05236036	Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma	active not recruiting	Phase 1	86	Northwestern UniversityOTHER	1	Aug 26, 2026	clinicaltrials
NCT06186401	Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells	recruiting	Phase 1	20	Hideho Okada, MD, PhDOTHER	1	Aug 13, 2026	clinicaltrials